David M. Knott Jr’s Travere Therapeutics TVTX Stock Holding History

David M. Knott Jr’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.65M	Sell	129,967 -17,315	-12%	-$1.06M	4.19%	6
2026 Q2	$8.37M	Buy	147,282 +6,649	+5%	+$295K	4.42%	5
2026 Q1	$4.18M	Sell	140,633 -45,367	-24%	-$1.36M	2.49%	12
2025 Q4	$7.11M	Sell	186,000 -74,000	-28%	-$2.41M	3.29%	6
2025 Q3	$6.21M	Hold	260,000	–	–	2.51%	9
2025 Q2	$3.85M	Buy	260,000 +32,000	+14%	+$530K	1.74%	10
2025 Q1	$4.09M	Hold	228,000	–	–	1.93%	11
2024 Q4	$3.97M	Sell	228,000 -30,231	-12%	-$535K	1.44%	12
2024 Q3	$3.61M	Sell	258,231 -7,735	-3%	-$80.6K	1.27%	19
2024 Q2	$2.19M	Buy	265,966 +35,000	+15%	+$236K	0.87%	25
2024 Q1	$1.78M	Buy	230,966 +9,961	+5%	+$84K	0.63%	31
2023 Q4	$1.99M	Buy	221,005 +120,688	+120%	+$879K	0.76%	23
2023 Q3	$897K	Buy	+100,317	New	+$1.42M	0.34%	40

Other funds holding TVTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

David M. Knott Jr's TVTX Position: Q3 2026 in Review

David M. Knott Jr reduced its Travere Therapeutics (TVTX) stake by 12% in Q3 2026, selling an estimated $1.06M and leaving 129,967 shares worth $7.65M. The position accounts for 4.19% of the portfolio, ranked #6.

David M. Knott Jr first reported a position in TVTX in Q3 2023 and has held it in 13 quarters since. The position peaked at $8.37M in Q2 2026. 198 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

David M. Knott Jr held 129,967 shares of Travere Therapeutics worth $7.65M as of Q3 2026.
David M. Knott Jr sold 17,315 Travere Therapeutics shares in Q3 2026, an estimated $1.06M.
Travere Therapeutics made up 4.19% of David M. Knott Jr's portfolio in Q3 2026, its #6 holding.
David M. Knott Jr first reported a position in Travere Therapeutics in Q3 2023 and has held it in 13 quarters since.
David M. Knott Jr's Travere Therapeutics position peaked at $8.37M in Q2 2026.
198 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on David M. Knott Jr's 13F filing for Q3 2026, filed 12 Nov 2026.